SINCLAIR ANDREW purchased 12.9% of their position (150K shares) of SIERRA ONCOLOGY, INC. on the open market
Open‑market purchase worth $4.05M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/1/2022ACC: 0000905718-22-000178
+150K
Net shares
Net buyer
$7.84M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
437.47K acquired · 287.47K disposed
Non-Derivative Transactions2
Common Stock, $0.001 par value
Indirect
Shares
+287.47K
Price / share
$13.20
Trade value
$3.79M
% of position
32.8%
1/28/2022
876.66K→1.16M
Common Stock, $0.001 par value
Indirect
Shares
+150K
Price / share
$27.00
Trade value
$4.05M
% of position
12.9%
1/31/2022
1.16M→1.31M
Total
Net shares
+437.47K
Net value
$7.84M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Indirect | 1/28/2022 | X · X | +287.47K | $13.20 | $3.79M | 32.8% | 876.66K | 1.16M |
| Common Stock, $0.001 par value Indirect | 1/31/2022 | P · Purchase | +150K | $27.00 | $4.05M | 12.9% | 1.16M | 1.31M |
| Total | +437.47K | $7.84M | ||||||
Derivative Transactions1
Series B Warrants (right to buy)
Indirect
Converts to
Common Stock
287.47K shares
Shares
−287.47K
Strike price
13.20
Held after
0.00
Exercisable
—
1/28/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Warrants (right to buy) Indirect | Common Stock287.47K shares | 1/28/2022 | X · X | −287.47K | 13.20 | — | 0.00 |